Literature DB >> 29264741

Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).

Akihiro Abe1, Yukiya Yamamoto2, Akira Katsumi3, Akinao Okamoto2, Masutaka Tokuda2, Yoko Inaguma2, Kiyoko Yamamoto2, Masamitsu Yanada2, Tadaharu Kanie2, Akihiro Tomita2, Yoshiki Akatsuka2, Masataka Okamoto2, Toshiki Kameyama4, Akila Mayeda4, Nobuhiko Emi2.   

Abstract

Variant chromosomal translocations associated with t(8;21) are observed in 3-4% of acute myeloid leukemia (AML) cases with a RUNX1-RUNX1T1 fusion gene. However, the molecular events that occur in variants of t(8;21) are not well characterized. In the present study, we report genetic features of a variant three-way translocation of t(8;12;21)(q22;p11;q22) in a patient with AML. In this patient, leukemia cells lacked azurophilic granules, which does not correspond with the classic features of t(8;21). RNA-seq analysis revealed that TM7SF3 at 12p11 was fused to VPS13B at 8q22 and VPS13B to RUNX1, in addition to RUNX1-RUNX1T1. VPS13B was located near RUNX1T1 and both were localized at the same chromosomal bands. The reading frames of TM7SF3 and VPS13B did not match to those of VPS13B and RUNX1, respectively. Disruption of VPS13B causes Cohen syndrome, which presents intermittent neutropenia with a left-shifted granulopoiesis in the bone marrow. Disruption of VPS13B may thus cause the unusual features of RUNX1-RUNX1T1 leukemia. Our case indicates that rearrangement of VPS13B may be additional genetic events in variant t(8;21).

Entities:  

Keywords:  3-Way translocation; AML; RUNX1–RUNX1T1; TM7SF3; VPS13B

Mesh:

Substances:

Year:  2017        PMID: 29264741     DOI: 10.1007/s12185-017-2387-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  20 in total

1.  Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.

Authors:  Guido Marcucci; Krzysztof Mrózek; Amy S Ruppert; Kati Maharry; Jonathan E Kolitz; Joseph O Moore; Robert J Mayer; Mark J Pettenati; Bayard L Powell; Colin G Edwards; Lisa J Sterling; James W Vardiman; Charles A Schiffer; Andrew J Carroll; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

2.  Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature.

Authors:  Li Huang; Lynne V Abruzzo; Jose R Valbuena; L Jeffrey Medeiros; Pei Lin
Journal:  Am J Clin Pathol       Date:  2006-02       Impact factor: 2.493

3.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Authors:  David Grimwade; Robert K Hills; Anthony V Moorman; Helen Walker; Stephen Chatters; Anthony H Goldstone; Keith Wheatley; Christine J Harrison; Alan K Burnett
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

4.  JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia 1. Acute myeloid leukemia (AML).

Authors:  Shuichi Miyawaki
Journal:  Int J Hematol       Date:  2017-08-07       Impact factor: 2.490

5.  Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia.

Authors:  J M Trujillo; A Cork; M J Ahearn; E L Youness; K B McCredie
Journal:  Blood       Date:  1979-04       Impact factor: 22.113

6.  Deletions in the VPS13B (COH1) gene as a cause of Cohen syndrome.

Authors:  I Balikova; A-E Lehesjoki; T J L de Ravel; B Thienpont; K E Chandler; J Clayton-Smith; A-L Träskelin; J-P Fryns; J R Vermeesch
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

7.  Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system.

Authors:  Olga K Weinberg; Mahesh Seetharam; Li Ren; Katie Seo; Lisa Ma; Jason D Merker; Jason Gotlib; James L Zehnder; Daniel A Arber
Journal:  Blood       Date:  2009-01-08       Impact factor: 22.113

8.  deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data.

Authors:  Andrew McPherson; Fereydoun Hormozdiari; Abdalnasser Zayed; Ryan Giuliany; Gavin Ha; Mark G F Sun; Malachi Griffith; Alireza Heravi Moussavi; Janine Senz; Nataliya Melnyk; Marina Pacheco; Marco A Marra; Martin Hirst; Torsten O Nielsen; S Cenk Sahinalp; David Huntsman; Sohrab P Shah
Journal:  PLoS Comput Biol       Date:  2011-05-19       Impact factor: 4.475

9.  TopHat-Fusion: an algorithm for discovery of novel fusion transcripts.

Authors:  Daehwan Kim; Steven L Salzberg
Journal:  Genome Biol       Date:  2011-08-11       Impact factor: 13.583

10.  Transcriptome sequencing to detect gene fusions in cancer.

Authors:  Christopher A Maher; Chandan Kumar-Sinha; Xuhong Cao; Shanker Kalyana-Sundaram; Bo Han; Xiaojun Jing; Lee Sam; Terrence Barrette; Nallasivam Palanisamy; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962

View more
  2 in total

Review 1.  Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies.

Authors:  Luiza Handschuh
Journal:  J Oncol       Date:  2019-07-30       Impact factor: 4.375

Review 2.  Elucidating miRNA Function in Cancer Biology via the Molecular Genetics' Toolbox.

Authors:  Adam Azlan; Yaashini Rajasegaran; Khor Kang Zi; Aliaa Arina Rosli; Mot Yee Yik; Narazah Mohd Yusoff; Olaf Heidenreich; Emmanuel Jairaj Moses
Journal:  Biomedicines       Date:  2022-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.